The Valley Desk

NCT01968980 · Interventional trial

A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia

Overall registry status Completed

Phase 3

Conditions Heterozygous Familial Hypercholesterolemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov